Merck KGaA
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more
Merck KGaA (MRK) - Total Liabilities
Latest total liabilities as of September 2025: €21.93 Billion EUR
Based on the latest financial reports, Merck KGaA (MRK) has total liabilities worth €21.93 Billion EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Merck KGaA - Total Liabilities Trend (2002–2024)
This chart illustrates how Merck KGaA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Merck KGaA Competitors by Total Liabilities
The table below lists competitors of Merck KGaA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mid-America Apartment Communities Inc
NYSE:MAA
|
USA | $5.91 Billion |
|
Moncler S.p.A.
PINK:MONRF
|
USA | $1.73 Billion |
|
China National Uranium Co Ltd
SHE:001280
|
China | CN¥14.46 Billion |
|
Lenovo Group Ltd PK
PINK:LNVGY
|
USA | $44.66 Billion |
|
Hindalco Industries Limited
NSE:HINDALCO
|
India | ₹1.62 Trillion |
|
Home Depot Inc. CEDEAR
BA:HD
|
Argentina | AR$94.16 Billion |
|
Deckers Outdoor Corporation
NYSE:DECK
|
USA | $1.49 Billion |
|
Viking Holdings Ltd
NYSE:VIK
|
USA | $10.72 Billion |
Liability Composition Analysis (2002–2024)
This chart breaks down Merck KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Merck KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Merck KGaA (2002–2024)
The table below shows the annual total liabilities of Merck KGaA from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €21.58 Billion | -0.74% |
| 2023-12-31 | €21.74 Billion | -3.47% |
| 2022-12-31 | €22.52 Billion | -5.95% |
| 2021-12-31 | €23.95 Billion | -3.36% |
| 2020-12-31 | €24.78 Billion | -4.32% |
| 2019-12-31 | €25.90 Billion | +31.76% |
| 2018-12-31 | €19.66 Billion | -8.81% |
| 2017-12-31 | €21.55 Billion | -10.93% |
| 2016-12-31 | €24.20 Billion | -3.78% |
| 2015-12-31 | €25.15 Billion | +77.01% |
| 2014-12-31 | €14.21 Billion | +45.74% |
| 2013-12-31 | €9.75 Billion | -13.17% |
| 2012-12-31 | €11.23 Billion | -3.42% |
| 2011-12-31 | €11.63 Billion | -3.24% |
| 2010-12-31 | €12.02 Billion | +66.91% |
| 2009-12-31 | €7.20 Billion | +19.50% |
| 2008-12-31 | €6.02 Billion | -3.38% |
| 2007-12-31 | €6.23 Billion | +45.16% |
| 2006-12-31 | €4.30 Billion | +8.69% |
| 2005-12-31 | €3.95 Billion | +39.77% |
| 2004-12-31 | €2.83 Billion | -38.79% |
| 2003-12-31 | €4.62 Billion | -15.36% |
| 2002-12-31 | €5.46 Billion | -- |